 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
- l8 s$ R, _, |2 G- T5 H , A* d+ t% U0 k( `! x
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.9 j* v/ K6 Q+ d m( p
! |- \1 i! Y" C
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007; x N3 z; D- z! J- ~
0 G; n: H0 d3 O( }
- W7 o+ Y7 V8 U# B! F4 O9 k% HEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.4 Z2 }* S6 \. ^8 S5 @- n, w: n3 |
3 I; l: y! [0 x% q
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."- F q9 ~( J# E
" e6 o0 U2 \" W5 ~' z# ^
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
' z- b) E8 p1 f/ T2 q
' s/ t6 g7 W5 T8 j' w0 c+ A8 AIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
% E2 N- M: m& O; @
# ^6 J% Q( l# g0 ~' W3 \2 f& MIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
' ^! {. A/ t1 p4 Z
! p. O) `2 S6 D$ }% C"As a scientist, it's one of the highlights of my CAREER," Shan said., E$ t& x. T- s8 m. u1 {2 ?) v
, q/ O M8 Q1 l9 j1 M
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
9 M" P( W8 W1 ~# C7 q
, \9 M/ u% q9 aIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
5 ^& s: ]" A* i3 f( h1 @& @% g( F i' ]8 Q5 Z R
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
' }/ e4 L$ D: t! D4 T" ~& ^) @ @! o2 y& ?! }& v/ Q$ p' m
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
9 q" {4 @7 P! K3 a9 ~0 |0 G& l
9 @$ W/ u* y" X1 B8 ]8 Q! z
' _ k/ M6 G# r' I$ R- s; ^& i( _http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|